Skip to main content

Tetrahydrozoline / zinc sulfate ophthalmic Pregnancy and Breastfeeding Warnings

Brand names: Visine A.C., Visine Totality Multi-Symptom Relief

Medically reviewed by Drugs.com. Last updated on Aug 14, 2023.

Tetrahydrozoline / zinc sulfate ophthalmic Pregnancy Warnings

Caution is recommended.

US FDA pregnancy category: Not formally assigned to a pregnancy category.

Animal studies have not been reported. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

See references

Tetrahydrozoline / zinc sulfate ophthalmic Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Data not available
Excreted into animal milk: Data not available

Comment: The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. (2003) "Product Information. Visine A.C. (tetrahydrozoline-zinc ophthalmic)." Pfizer U.S. Pharmaceuticals Group

References for breastfeeding information

  1. (2003) "Product Information. Visine A.C. (tetrahydrozoline-zinc ophthalmic)." Pfizer U.S. Pharmaceuticals Group

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer